Plant ID: NPO16884
Plant Latin Name: Convallaria keiskei
Taxonomy Genus: Convallaria
Taxonomy Family: Asparagaceae
NCBI TaxonomyDB:
182176
Plant-of-the-World-Online:
533481-1
Myanmar; South Africa; Mongolia; China; Japan; South Korea; Russia
GPBAR1; | |
ALPL; HSD17B10; | |
GAA; | |
NR1H4; | |
NFKB1; | |
MAPT; LMNA; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P05186 | CHEMBL5979 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Small molecule receptor (family A GPCR) | GPBAR1 | G-protein coupled bile acid receptor 1 | Q8TDU6 | CHEMBL5409 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 4.502E-07 | 4.902E-03 | GPBAR1, NR1H4 |
BP | GO:0008152; metabolic process | GO:0010894; negative regulation of steroid biosynthetic process | 3.781E-05 | 2.440E-01 | NFKB1, NR1H4 |
BP | GO:0050896; response to stimulus | GO:0032496; response to lipopolysaccharide | 1.549E-04 | 2.577E-01 | ALPL, NFKB1, NR1H4 |
MF | GO:0005488; binding | GO:0000980; RNA polymerase II distal enhancer sequence-specific DNA binding | 3.781E-04 | 2.577E-01 | NFKB1, NR1H4 |
MF | GO:0140110; transcription regulator activity | GO:0003705; transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding | 7.136E-04 | 3.920E-01 | NFKB1, NR1H4 |
CC | GO:0032991; macromolecular complex | GO:0033256; I-kappaB/NF-kappaB complex | 2.896E-03 | 5.532E-01 | NFKB1 |
CC | GO:0044464; cell part | GO:0030673; axolemma | 6.609E-03 | 7.495E-01 | MAPT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 1.325E-03 | 5.984E-02 | LMNA, NFKB1 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 1.900E-03 | 5.984E-02 | MAPT, HSD17B10 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04010 | MAPK signaling pathway | 4.310E-03 | 6.633E-02 | MAPT, NFKB1 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.049E-02 | 6.633E-02 | GAA, ALPL, HSD17B10 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00280 | Valine, leucine and isoleucine degradation | 1.904E-02 | 6.633E-02 | HSD17B10 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00500 | Starch and sucrose metabolism | 2.219E-02 | 6.633E-02 | GAA |
09160 Human Diseases | 09164 Substance dependence | hsa05030 | Cocaine addiction | 1.944E-02 | 6.633E-02 | NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 2.258E-02 | 6.633E-02 | NFKB1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 1.194E-02 | 6.633E-02 | GAA |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.970E-02 | 6.633E-02 | NFKB1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Anthelmintic | B89 | ALPL; |
C00-D49: Neoplasms | Colon cancer | C50 | ALPL; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; |
Q00-Q99: Congenital malformations, deformations and chromosomal abnormalities | Genetic disease | Q00-Q99 | ALPL; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; |